Altria Faces Probe Over Misleading Investor Claims

Altria Group is under investigation for potentially misleading investors about the FDA status of its on! PLUS nicotine pouch product. Levi & Korsinsky, a legal firm, is checking if Altria's claims about the product's regulatory approval and expected authorizations were accurate. This comes after Altria's stock dropped following disappointing second-quarter results. What does it mean for you? If you invested in Altria and lost money, this investigation might lead to a chance for you to recover some of your losses. You might want to check your investment records and consider getting in touch with Levi & Korsinsky for a free evaluation.

Original source Read the full story →
More from this briefing
Rackspace Faces Lawsuit Over Investor Misleading Rackspace Faces Lawsuit Over Misleading AI Focus Insulet Faces Lawsuit Over Misleading Manufacturing Claims Genius Group Faces Class Action Over Stock Fraud ADMA Biologics Faces Investor Fraud Lawsuit Futu Faces Legal Battle Over Investor Losses Bloom Energy Faces Lawsuit Over Hidden Scandium Reliance PepsiCo Goes Green with Low-Carbon Ammonia PepsiCo Partners with Envision for Greener Fertilizers Envision Energy, PepsiCo Partner for Greener Agriculture Black Rock Coffee Sued Over Expansion Missteps Teladoc Stock Crashes 30% Amid Revenue Woes Maryland's Business Boom: Jobs, Healthcare, and Space Projects Home Depot Revamps Leadership for Enhanced Shopping Experience Allspring Funds Adjust Monthly Payouts Slightly

Get stories like this every morning.

Five-minute intelligence briefing — in your inbox at 6 AM.

Subscribe now